NYSE - Delayed Quote USD

Qiagen N.V. (QGEN)

47.11
-0.28
(-0.59%)
At close: June 13 at 4:00:02 PM EDT
47.17
+0.06
+(0.13%)
Pre-Market: 6:34:16 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,002,874
1,978,214
1,965,311
2,141,518
2,251,657
Cost of Revenue
1,017,832
1,010,864
731,623
756,955
800,837
Gross Profit
985,042
967,350
1,233,688
1,384,563
1,450,820
Operating Expense
758,225
767,451
788,441
808,335
792,974
Operating Income
226,817
199,899
445,247
576,228
657,846
Net Non Operating Interest Income Expense
24,805
24,175
25,582
-25,600
-44,922
Other Income Expense
-113,222
-102,927
-41,020
-38,027
12,909
Pretax Income
138,406
121,147
429,809
512,601
625,833
Tax Provision
44,730
37,556
88,506
89,390
113,234
Net Income Common Stockholders
93,676
83,591
341,303
423,211
512,599
Diluted NI Available to Com Stockholders
93,676
83,591
341,303
423,211
512,599
Basic EPS
0.45
0.39
1.59
2.68
2.39
Diluted EPS
0.43
0.38
1.57
2.65
2.34
Basic Average Shares
215,070.64
216,435.14
215,207.88
214,617.75
214,143.36
Diluted Average Shares
216,879.11
218,474.86
217,486.53
217,031.03
218,820.95
Total Operating Income as Reported
118,111
97,711
409,938
531,460
630,084
Total Expenses
1,776,057
1,778,315
1,520,064
1,565,290
1,593,811
Net Income from Continuing & Discontinued Operation
93,676
83,591
341,303
423,211
512,599
Normalized Income
169,822.35
154,100.72
369,338.35
460,172.13
535,336.08
Interest Income
65,648
68,016
78,992
32,757
9,555
Interest Expense
40,843
43,841
53,410
58,357
54,477
Net Interest Income
24,805
24,175
25,582
-25,600
-44,922
EBIT
179,249
164,988
483,219
570,958
680,310
EBITDA
372,095
368,256
688,555
779,355
895,241
Reconciled Cost of Revenue
833,653
817,192
537,051
563,089
604,448
Reconciled Depreciation
192,846
203,268
205,336
208,397
214,931
Net Income from Continuing Operation Net Minority Interest
93,676
83,591
341,303
423,211
512,599
Total Unusual Items Excluding Goodwill
-112,506
-102,188
-35,309
-44,768
-27,762
Total Unusual Items
-112,506
-102,188
-35,309
-44,768
-27,762
Normalized EBITDA
484,601
470,444
723,864
824,123
923,003
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-36,359.65
-31,678.28
-7,273.65
-7,806.87
-5,024.92
12/31/2021 - 6/28/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MYGN Myriad Genetics, Inc.
5.03
-3.08%
 
RVTY Revvity, Inc.
93.53
-2.27%
 
300676.SZ BGI Genomics Co., Ltd.
50.08
+0.16%
 
CRL Charles River Laboratories International, Inc.
149.45
-1.61%
 
WAT Waters Corporation
342.30
-2.08%
 
SHC Sotera Health Company
11.43
-2.72%
 
TWST Twist Bioscience Corporation
33.52
-0.33%
 
CSTL Castle Biosciences, Inc.
18.75
-0.37%
 
GH Guardant Health, Inc.
49.29
+0.55%
 
DGX Quest Diagnostics Incorporated
180.21
+0.65%